Re‐evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs

In 2015, EFSA established a temporary tolerable daily intake (t‐TDI) for BPA of 4 μg/kg body weight (bw) per day. In 2016, the European Commission mandated EFSA to re‐evaluate the risks to public health from the presence of BPA in foodstuffs and to establish a tolerable daily intake (TDI). For this...

Full description

Saved in:
Bibliographic Details
Published inEFSA journal Vol. 21; no. 4; pp. e06857 - n/a
Main Authors Lambré, Claude, Barat Baviera, José Manuel, Bolognesi, Claudia, Chesson, Andrew, Cocconcelli, Pier Sandro, Crebelli, Riccardo, Gott, David Michael, Grob, Konrad, Lampi, Evgenia, Mengelers, Marcel, Mortensen, Alicja, Rivière, Gilles, Silano (until 21 December 2020†), Vittorio, Steffensen, Inger‐Lise, Tlustos, Christina, Vernis, Laurence, Zorn, Holger, Batke, Monika, Bignami, Margherita, Corsini, Emanuela, FitzGerald, Rex, Gundert‐Remy, Ursula, Halldorsson, Thorhallur, Hart, Andrew, Ntzani, Evangelia, Scanziani, Eugenio, Schroeder, Henri, Ulbrich, Beate, Waalkens‐Berendsen, Dina, Woelfle, Detlef, Al Harraq, Zainab, Baert, Katleen, Carfì, Maria, Castoldi, Anna F, Croera, Cristina, Van Loveren, Henk
Format Journal Article
LanguageEnglish
Published United States John Wiley & Sons, Inc 01.04.2023
European Food Safety Authority
John Wiley and Sons Inc
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In 2015, EFSA established a temporary tolerable daily intake (t‐TDI) for BPA of 4 μg/kg body weight (bw) per day. In 2016, the European Commission mandated EFSA to re‐evaluate the risks to public health from the presence of BPA in foodstuffs and to establish a tolerable daily intake (TDI). For this re‐evaluation, a pre‐established protocol was used that had undergone public consultation. The CEP Panel concluded that it is Unlikely to Very Unlikely that BPA presents a genotoxic hazard through a direct mechanism. Taking into consideration the evidence from animal data and support from human observational studies, the immune system was identified as most sensitive to BPA exposure. An effect on Th17 cells in mice was identified as the critical effect; these cells are pivotal in cellular immune mechanisms and involved in the development of inflammatory conditions, including autoimmunity and lung inflammation. A reference point (RP) of 8.2 ng/kg bw per day, expressed as human equivalent dose, was identified for the critical effect. Uncertainty analysis assessed a probability of 57–73% that the lowest estimated Benchmark Dose (BMD) for other health effects was below the RP based on Th17 cells. In view of this, the CEP Panel judged that an additional uncertainty factor (UF) of 2 was needed for establishing the TDI. Applying an overall UF of 50 to the RP, a TDI of 0.2 ng BPA/kg bw per day was established. Comparison of this TDI with the dietary exposure estimates from the 2015 EFSA opinion showed that both the mean and the 95th percentile dietary exposures in all age groups exceeded the TDI by two to three orders of magnitude. Even considering the uncertainty in the exposure assessment, the exceedance being so large, the CEP Panel concluded that there is a health concern from dietary BPA exposure. This publication is linked to the following EFSA Journal article: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2023.p210401/full
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Panel members: José Manuel Barat Baviera, Claudia Bolognesi, Andrew Chesson, Pier Sandro Cocconcelli, Riccardo Crebelli, David Michael Gott, Konrad Grob, Claude Lambré, Evgenia Lampi, Marcel Mengelers, Alicja Mortensen, Gilles Rivière, Vittorio Silano (until 21 December 2020†), Inger‐Lise Steffensen, Christina Tlustos, Henk Van Loveren, Laurence Vernis and Holger Zorn.
Acknowledgements: The CEP Panel wishes to thank the following for the support provided to this scientific output as members of the cross‐cutting WG on uncertainty: Peter Craig and Ullrika Sahlin; as members of the WG on BPA re‐evaluation: Laurent Bodin, Celine Brochot, Hans Mielke and Natalie von Goetz; as hearing experts of the WG on BPA re‐evaluation: Marc Pallardy, Diane Benford, Susanne Hougaard Bennekou, Josef Schlatter and EFSA staff members: Fulvio Barizzone, Federica Barrucci, Matilde Benedettini, Daniele Comandella, José Cortiñas Abrahantes, Fatima Den Ouden, Esraa Elewa, Chantra Eskes, Natalia Kovalkovičová, Foteini Pantazi, Sandra Rainieri, Ellen Van Haver. The CEP Panel wishes to acknowledge all European competent institutions, Member State bodies and other organisations that provided data for this scientific output. The Panel would also like to thank the following authors for providing additional information in relation to their respective studies: Tong Shen, Glaura Scantamburlo A. Fernandes, Marisa Bartolomei and Enrique H Luque.
Note: A plain language summary of this scientific opinion is available at https://efsa.onlinelibrary.wiley.com/doi/full/10.2903/j.efsa.2023.P210401
This publication is linked to the following EFSA Journal article: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2023.p210401/full
Copyright for non‐EFSA content EFSA may include images or other content for which it does not hold copyright. In such cases, EFSA indicates the copyright holder and users should seek permission to reproduce the content from the original source.
Annexes A–N are available under the Supporting Information section .
EFSA may include images or other content for which it does not hold copyright. In such cases, EFSA indicates the copyright holder and users should seek permission to reproduce the content from the original source.
Adopted: 6 December 2022
Question number: EFSA‐Q‐2016‐00635
Declarations of interest: If you wish to access the declaration of interests of any expert contributing to an EFSA scientific assessment, please contact interestmanagement@efsa.europa.eu.
Requestor: European Commission
ISSN:1831-4732
1831-4732
DOI:10.2903/j.efsa.2023.6857